World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2026

D-Index & Metrics

Medicine

D-Index
165
Citations
119728
World Ranking
627
National Ranking
76

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award

Overview

Paul D.P. Pharoah is a researcher affiliated with the University of Cambridge in the United Kingdom. Their work primarily spans the disciplines of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine. Within these broad fields, their research delves into subfields such as Genetics, Molecular Biology, Oncology, Cancer Research, and Reproductive Medicine.

Their research topics cover key areas in cancer genetics and epidemiology. These include BRCA gene mutations in cancer, genetic associations and epidemiology, ovarian cancer diagnosis and treatment, cancer genomics and diagnostics, genetic factors in colorectal cancer, global cancer incidence and screening, and breast cancer treatment studies.

Pharoah has published extensively across multiple scientific venues. Frequent publication outlets include bioRxiv (Cold Spring Harbor Laboratory), Cancer Research, UNC Libraries, Cancer Epidemiology Biomarkers & Prevention, and the British Journal of Cancer. These journals reflect a consistent focus on cancer biology and epidemiology.

Among their recent notable papers are:

  • "Cancer therapy shapes the fitness landscape of clonal hematopoiesis" (2020, Nature Genetics)
  • "Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis" (2020, Nature Communications)
  • "Multi-omic machine learning predictor of breast cancer therapy response" (2021, Nature)
  • "Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic" (2020, Annals of Oncology)
  • "Personalized early detection and prevention of breast cancer: ENVISION consensus statement" (2020, Nature Reviews Clinical Oncology)

Their frequent co-authors include Douglas F. Easton, Jenny Chang-Claude, Alison M. Dunning, Manjeet K. Bolla, and Montserrat García-Closas. These collaborations indicate a strong network within the cancer genetics and epidemiology research community.

Best Publications

  • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

    A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • The clonal and mutational evolution spectrum of primary triple-negative breast cancers

    Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.

    Gillian C. Barnett;Gillian C. Barnett;Charlotte E. Coles;Rebecca M. Elliott;Caroline Baynes

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

    David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • RAD51B in Familial Breast Cancer

    Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski

  • Polygenic susceptibility to breast cancer and implications for prevention

    Paul D.P. Pharoah;Antonis Antoniou;Martin Bobrow;Ron L. Zimmern

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Family history and the risk of breast cancer: A systematic review and meta‐analysis

    Paul D.P. Pharoah;Nicholas E. Day;Stephen Duffy;Douglas F. Easton

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

    Gillian C. Barnett;Catherine M. L. West;Alison M. Dunning;Rebecca M. Elliott

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Genome-wide association study identifies five new breast cancer susceptibility loci

    Clare Turnbull;Shahana Ahmed;Jonathan Morrison;David Pernet

  • p53 polymorphisms: cancer implications

    Catherine Whibley;Paul D. P. Pharoah;Monica Hollstein

Frequent Co-Authors

Graham G. Giles
Graham G. Giles University of Melbourne
Douglas F. Easton
Douglas F. Easton University of Cambridge
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Alison M. Dunning
Alison M. Dunning University of Cambridge
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Melissa C. Southey
Melissa C. Southey Monash University
Montserrat Garcia-Closas
Montserrat Garcia-Closas National Institutes of Health
Susan J. Ramus
Susan J. Ramus University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary pathways in healthcare is a smart move for those interested in Medicine in the USA. Many professionals consider advancing their education online for greater flexibility and career opportunities. One major factor is understanding how to evaluate healthcare administration degree programs, ensuring they hold proper accreditation and offer valuable skills for future leaders in healthcare.

For registered nurses seeking career growth, accredited rn to bsn online no clinicals accredited options provide added convenience without the need for additional clinical hours. For those aiming for higher credentials, there are also dnp online programs that can be completed faster, helping you achieve your Doctor of Nursing Practice degree efficiently.

Cost is important too—many students research affordable dnp programs to reduce financial barriers while still advancing their professional prospects. These online degree options support a wide range of career aspirations and offer flexibility for working students or those seeking to change their career pathway after studying Medicine in the USA.

Best Scientists Citing Paul D.P. Pharoah

Trending Scientists